Skip to main content
Abraham Jacob, MD, Cardiology, Madison, WI

Abraham Jacob MD

Adult Congenital Heart Disease, Interventional Cardiology, Peripheral Endovascular Interventional Cardiology, Preventive Cardiology


Physician

Join to View Full Profile
  • 2601 W Beltline HwySte 200Madison, WI 53713

  • Phone+1 608-287-2434

  • Fax+1 972-521-3394

Dr. Jacob is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • MercyOne Des Moines Medical Center
    MercyOne Des Moines Medical Center2001 - 2002
  • University of Kansas School of Medicine
    University of Kansas School of MedicineFellowship, Cardiovascular Disease, 1998 - 2001
  • University of Kansas School of Medicine
    University of Kansas School of MedicineResidency, Internal Medicine, 1995 - 1998
  • American University of the Caribbean School of Medicine
    American University of the Caribbean School of MedicineClass of 1994

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2020 - 2027
  • OK State Medical License
    OK State Medical License 2024 - 2025
  • TX State Medical License
    TX State Medical License 2002 - 2025
  • WI State Medical License
    WI State Medical License 2020 - 2025
  • IA State Medical License
    IA State Medical License 2001 - 2003
  • Cardiovascular Disease
    American Board of Internal Medicine Cardiovascular Disease

Awards, Honors, & Recognition

  • Fellow (FACC) American College of Cardiology

Research History

  • Medical MonitorArteriocyte "Phase I, Non-Randomized, Feasibility Study for the use of autologous marrow-derived hematopoietic stem cells with autologous platelet-rich plasma for the treatment of compartment syndrome." A Department of Defense project.2012 - Present
  • Medical MonitorArteriocyte “Phase I, Non-Randomized, Feasibility study for the use of bone marrow cell concentrate prepared using the Magellan system for the treatment of critical limb ischemia”.2011 - Present

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: